Circulating angiotensin converting enzyme activity is correlated with muscle strength

Medicine and Science in Sports and Exercise

Volumn 37, Issue 6, 2005, Pages 944-948

  Williams, Alun G ^a   Day, Stephen H ^b   Folland, Jonathan P ^c   Gohlke, Peter ^d   Dhamrait, Sukhbir ^e   Montgomery, Hugh E ^e  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Force; Genetics; Training

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; ISOKINETIC EXERCISE; MALE; MUSCLE STRENGTH; NORMAL HUMAN; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; TRAINING;

ADOLESCENT; ADULT; EXERCISE; HUMANS; JAPAN; MALE; MUSCLE, SKELETAL; PEPTIDYL-DIPEPTIDASE A;

EID: 20544462253     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000166577.42935.4e     Document Type: Article

References (31)

1. DANSER, A. H., M. A. SCHALEKAMP, W. A. BAX, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertionpolymorphism. Circulation 92:1387-1388, 1995.
2. DAY, S. H., C. WILLIAMS, J. P. FOLLAND, P. GOHLKE, and A. G. WILLIAMS. The acute effects of exercise and glucose ingestion on circulating angiotensin-converting enzyme in humans. Eur. J. Appl. Physiol. 92:579-583, 2004.
3. DEPIERRE, D., and M. ROTH. Fluorimetric determination of dipeptidyl carboxypeptidase. (angiotensin-I-converting enzyme). Enzyme 19:65-70, 1975.
4. DOSTAL, D. E., and K. M. BAKER. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: mediation by the AT1 receptor. Am. J. Hypertens. 5:276-280, 1992.
5. DUX, S., N. ARON, G. BONER, A. CARMEL, A. YARON, and J. B. ROSENFELD. Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. Isr. J. Med. Sci. 20:1138-1142, 1984.
6. DZAU, V. J. Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction. Circulation 77:11-3, 1988.
7. DZAU, V. J., K. BERNSTEIN, D. CELERMAJER, et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am. J. Cardiol. 88:1L-20L, 2001.
8. EMANUELI, C., R. MAESTRI, D. CORRADI, et al. Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice. Circulation 100:2359-2365, 1999.
9. FIGUEROA, C. D., G. DIETZE, and W. MULLER-ESTERL. Immunolocalization of bradykinin B2 receptors on skeletal muscle cells. Diabetes 45(Suppl. 1):S24-28, 1996.
10. FOLLAND, J., B. LEACH, T. LITTLE, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp. Physiol. 85:575-579, 2000.
11. GEISTERFER, A. A., M. J. PEACH, and G. K. OWENS. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-756, 1988.
12. GORDON, S. E., B. S. DAVIS, C. J. CARLSON, and F. W. BOOTH. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am. J. Physiol. 280:E150-159, 2001.
13. HOPKINSON, N. S., A. H. NICKOL, J. PAYNE, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170:395-399, 2004.
14. ISHIGAI, Y., T. MORI, T. IKEDA, A. FUKUZAWA, and T. SHIBANO. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes. Am. J. Physiol. 273: H2659-2663, 1997.
15. LANGBERG, H., C. BJORN, R. BOUSHEL, Y. HELLSTEN, and M. KJAER. Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J. Physiol. (Lond.) 542:977-983, 2002.
16. MAYFIELD, R. K., N. SHIMOJO, and A. A. JAFFA. Skeletal muscle kallikrein: potential role in metabolic regulation. Diabetes 45(Suppl. 1):S20-23, 1996.
17. MONTGOMERY, H., S. HUMPHRIES, and S. DANILOV. Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease? Eur. Heart J. 23:1083-1086, 2002.
18. MONTGOMERY, H. E., P. CLARKSON, C. M. DOLLERY, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741-747, 1997.
19. NARICI, M. V., H. HOPPELER, B. KAYSER, et al. Human quadriceps cross-sectional area, torque and neural activation during 6 months strength training. Acta Physiol. Scand. 157:175-186, 1996.
20. NORREGAARD, J., J. J. LYKKEGAARD, P. M. BULOW, and B. DANNESKIOLD-SAMSOE. The twitch interpolation technique for the estimation of true quadriceps muscle strength. Clin. Physiol. 17:523-532, 1997.
21. PARKER, D. F., J. M. ROUND, P. SACCO, and D. A. JONES. A cross-sectional survey of upper and lower limb strength in boys and girls during childhood and adolescence. Ann. Hum. Biol. 17:199-211, 1990.
22. PRATT, R. E. Angiotensin II and the control of cardiovascular structure. J. Am. Soc. Nephrol 10:8120-128, 1999.
23. RABITO, S. F., R. D. MINSHALL, F. NAKAMURA, and L.-X. WANG. Bradykinin B2 receptors on skeletal muscle are coupled to inositol 1,4,5-triphosphate formation. Diabetes 45:829-33, 1996.
24. RENELAND, R., and H. LITHELL. Angiotensin-converting enzyme in human skeletal muscle: a simple in vitro assay of activity in needle biopsy specimens. Scand. J. Clin. Lab. Invest. 54:105-111, 1994.
25. RIGAT, B., C., HUBERT, F. ALHENC-UELAS, F. CAMBIEN, P. CORVOL, and F. SOUBRIER. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1343-1346, 1990.
26. RUTHERFORD, O. M., D. A. JONES, and D. J. NEWHAM. Clinical and experimental application of the percutaneous twitch superimposition technique for the study of human muscle activation. J. Neurol. Neurosurg. Psychiatry 49:1288-1291, 1986.
27. STIENEN, G. J., J. L. KIERS, R. BOTTINELLI, and C. REGGIANI. Myofibrillar ATPase activity in skinned human skeletal muscle fibres: fibre type and temperature dependence. J. Physiol. (Lond.) 493(Pt 2):299-307, 1996.
28. THOMIS, M. A., W. HUYGENS, S. HEUNINCKX, et al. Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur. J. Appl. Physiol. 92:267-274, 2004.
29. UNGER, T., B. SCHULL, W. RASCHER, R. E. LANG, and D. GANTEN. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem. Pharmacol. 31:3063-3070, 1982.
30. WALI, F. A. Effect of angiotensin II on mechanical and electrical responses of frog, chick and rat skeletal muscle. Arch. Int. Pharmacodyn. Ther. 282:314-327, 1986.
31. ZHANG, B., H. TANAKA, N. SHONO, et al. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin. Genet. 63:139-144, 2003.